ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,091, issued on Jan. 20, was assigned to Trustees of Dartmouth College (Hanover, N.H.) and Memorial Sloan Kettering Cancer Center (New York).
"ATAC-array for prediction of disease-free survival in pancreatic cancer" was invented by Surajit Dhara (Hanover, N.H.), Steven D. Leach (Hanover, N.H.), Sagar Chhangawala (New York) and Christina Leslie (New York).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an array-based assay for transposase-accessible chromatin and prognostic molecular markers of treatment-resistant/early recurrent cancer. The present disclosure also relates to predicting an outcome, such as duration of d...